Efidac-24 Chlorpheniramine Side Effects
Generic Name: chlorpheniramine maleate, dexchlorpheniramine maleate
Please note - some side effects for Efidac-24 Chlorpheniramine may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
Side Effects by Body System - for Healthcare Professionals
Applies to: compounding powder; injectable solution; oral capsule, extended release; oral liquid; oral suspension, extended release; oral syrup; oral tablet; oral tablet, chewable; oral tablet, extended release
Nervous system
Central nervous system side effects have included depression resulting in drowsiness in 75% or more of treated patients. Dyskinesias have rarely been reported following chronic use of chlorpheniramine.
Nearly all patients treated with chlorpheniramine experience drowsiness. This drowsiness may subside in some patients with extended use.
Few cases of dyskinesias and tremors, often of the face, have been reported in patients whose chronic use of chlorpheniramine extended over a period of 3 to 10 years. Some of these cases were only partially relieved by discontinuation of the drug. Haloperidol was successful in relieving symptoms.
Gastrointestinal
Gastrointestinal side effects have included dry mouth and constipation in up to one-third of treated patients.
Cardiovascular
Cardiovascular side effects have included hypotension, tachycardia, and palpitations.
Ocular
Ocular side effects of chlorpheniramine may include blurred vision, diplopia, and dry eyes due to anticholinergic effects.
Genitourinary
Genitourinary side effects have included dysuria, urinary hesitancy, and a decreased urine flow. In rare cases, the anticholinergic effect of chlorpheniramine has precipitated acute urinary retention.
Hematologic
Hematologic side effects have included bone marrow suppression, thrombocytopenia, and aplastic anemia.
A fatal case of agranulocytosis has been reported in a patient taking chlorpheniramine, pseudoephedrine, acetaminophen, dextromethorphan, phenylpropanolamine, and aspirin. Chlorpheniramine was felt to be the cause.
Top- Efidac-24 Chlorpheniramine Concise Consumer Information (Cerner Multum)
- Ahist MedFacts Consumer Leaflet (Wolters Kluwer)
- Aller-Chlor syrup MedFacts Consumer Leaflet (Wolters Kluwer)
- Chlorpheniramine Maleate, Dexchlorpheniramine Maleate Monograph (AHFS DI)
- Ed ChlorPed suspension drops MedFacts Consumer Leaflet (Wolters Kluwer)
- Pediox-S suspension MedFacts Consumer Leaflet (Wolters Kluwer)
- QDALL AR sustained-release capsules MedFacts Consumer Leaflet (Wolters Kluwer)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


